Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.

History

 
1936 Nov. Toyama Chemical Co., Ltd., established around the business of Toyama Chemical Research Laboratory
1961 Feb. Head office relocated from Toyama to Nihonbashi, Tokyo
Oct. Listed on the second section of the Tokyo Stock Exchange
1970 Dec. General Research Laboratory completed
1971 Aug. Factory for the manufacture of injectable products completed
1972 Apr. Listed on the first section of the Tokyo Stock Exchange
Jun. First phase of pharmaceutical factory completed
1975 May No. 2 Research Laboratory completed
Aug. Second phase of pharmaceutical factory completed
1978 Feb. Head office relocated from Nihonbashi to Shinjuku, Tokyo
1980 Feb. PENTCILLIN injection and intramuscular introduced
Oct. No. 3 Research Laboratory completed
1981 Sep. ABOVIS capsules introduced
Dec. CEFOPERAZIN injection and intramuscular introduced
1982 Aug. BAXO capsules introduced
1985 Jun. No. 5 Research Laboratory completed
Jul. TOMIPORAN intravenous introduced
1986 Nov. BAXO ointment introduced
1987 Sep. TOMIRON tablet introduced
1988 Dec. BAXO suppositories introduced
1989 Nov. No. 1 Research Laboratory completed
1990 Apr. OZEX tablet introduced
Sep. TOMIRON fine granules introduced
1992 Jun. SELECAL tablet introduced
1993 Jun. SARPUL tablet introduced
Sep. New York Office opened
1994 Jan. FLUCAM capsules introduced
Nov. Sales of consumer healthcare products started
1996 Oct. London Office opened
1997 Oct. TOYAMA USA INC. established
1998 Oct. TOYAMA EUROPE LTD. established
Pharmaceutical factory and distribution wing completed
1999 Feb. JAPAN TISSUE ENGINEERING CO., LTD. established
Dec. LUPRAC tablet introduced
2000 Sep. Toyama Works and the 2nd Toyama Factory acquired ISO 14001 certification
2001 Jun. TAZOCIN intravenous introduced
2002 Apr. HALOSPOR intravenous introduced
Aug. Agreed on a strategic capital and business alliance with Taisho Pharmaceutical Co., Ltd.
Sep. PASIL intravenous drip introduced
Oct. Taisho Toyama Pharmaceutical Co., Ltd. established
2003 Feb. PENTCILLIN intravenous bag introduced
Transferred OTC business to Taisho Pharmaceutical and Kyorin Pharmaceutical Co., Ltd.
2006 May OZEX ophthalmic solution introduced
Oct. The entire company acquired ISO 14001 certification
Nov. No. 6 Research Laboratory completed
2007 Oct. GENINAX tablet introduced
2008 Feb. Agreed on a strategic capital and business alliance between FUJIFILM Holdings Corporation, Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd.
Aug. Delisted on the first section of the Tokyo Stock Exchange
Oct. ZOSYN intravenous introduced
2010 Jan. OZEX fine granules introduced
2012 Aug. No. 7 Research Laboratory completed
Sep. KOLBET tablet introduced
2013 Apr. Factory for the manufacture of injectable products completed
2014 Mar. Factory for the manufacture of injectable bag products completed
2015 Jun. ZOSYN intravenous bag introduced

Footer starts here.

Pages ends here.
Move to top of the page.